FDG-PET imaging in the management of non-small-cell lung cancer

被引：9
|
作者：
Salminen, E
Mac Manus, M
机构：
[1] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland
[2] Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia
来源：
ANNALS OF ONCOLOGY | 2002年 / 13卷 / 03期
关键词：
FDG-PET; non-small-cell lung cancer; outcome; staging; treatment;
D O I：
10.1093/annonc/mdf106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Lung cancer is currently the leading cause of cancer-related death in both men and women in most Western countries. Tumour stage is the strongest prognostic factor and the most important parameter guiding treatment decision making. Metabolic positron emission tomography imaging with fluorodeoxyglucose (FDG-PET) has consistently proved superior to conventional imaging for staging of non-small-cell lung cancer and provides information of greater prognostic significance than can be obtained using conventional approaches. FDG-PET has been approved in the USA. Germany and the UK as a basic and invaluable tool in the management of lung cancer.
引用
收藏
页码：357 / 360
页数：4
相关论文
共 50 条
  • [41] Prognostic value of [18F]FDG-PET imaging in small cell lung cancer
    Neeta Pandit
    Mithat Gonen
    Lee Krug
    Steven M. Larson
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : 78 - 84
  • [42] Prognostic value of [18F]FDG-PET imaging in small cell lung cancer
    Pandit, N
    Gonen, M
    Krug, L
    Larson, SM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (01) : 78 - 84
  • [43] FDG-PET/CT Imaging for Mediastinal Staging in Patients With Potentially Resectable Non-Small Cell Lung Cancer
    Schmidt-Hansen, Mia
    Baldwin, David Raymond
    Zamora, Javier
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (14): : 1465 - 1466
  • [44] Diagnosis of recurrence and follow-up using FDG-PET/CT for postoperative non-small-cell lung cancer patients
    Toba, Hiroaki
    Kawakita, Naoya
    Takashima, Mika
    Matsumoto, Daisuke
    Takizawa, Hiromitsu
    Otsuka, Hideki
    Tangoku, Akira
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2021, 69 (02) : 311 - 317
  • [45] FDG-PET does not predict outcome for early stage non-small-cell lung cancer after sterotactic body radiotherapy
    Saldi, S.
    Arcidiacono, F.
    Bellavita, R.
    Baffa, N.
    Falcinelli, L.
    Montesi, G.
    Arena, E.
    Porcari, M.
    Paglione, F.
    Bini, V.
    Aristei, C.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S642 - S642
  • [46] Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with non-small-cell lung cancer
    Nishiyama, Yoshihiro
    Yamamoto, Yuka
    Kimura, Naruhide
    Ishikawa, Shinya
    Sasakawa, Yasuhiro
    Ohkawa, Motoomi
    ANNALS OF NUCLEAR MEDICINE, 2008, 22 (04) : 245 - 250
  • [47] Diagnosis of recurrence and follow-up using FDG-PET/CT for postoperative non-small-cell lung cancer patients
    Hiroaki Toba
    Naoya Kawakita
    Mika Takashima
    Daisuke Matsumoto
    Hiromitsu Takizawa
    Hideki Otsuka
    Akira Tangoku
    General Thoracic and Cardiovascular Surgery, 2021, 69 : 311 - 317
  • [48] CT, MR, and PET imaging in staging of non-small-cell lung cancer
    Erasmus, JJ
    Truong, MT
    Munden, RF
    SEMINARS IN ROENTGENOLOGY, 2005, 40 (02) : 126 - 142
  • [49] The usefulness of FDG-PET to determine preoperative M-staging status in patients with non-small-cell lung cancer.
    Turkmen, C
    Sonmezoglu, K
    Utkusavas, A
    Erelel, M
    Ece, T
    Bozluolcay, S
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 384P - 385P
  • [50] An individualized radiation dose escalation trial in non-small cell lung cancer, based on FDG-PET imaging
    Wanet, M.
    Delor, A.
    Remouchamps, V.
    Goossens, S.
    Lee, J. A.
    Janssens, G.
    Hanin, F. X.
    Van Maanen, A.
    Geets, X.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S17 - S17
12345